https://www.taxtmi.com/caselaws?id=51685 A bulk drug treated as a medicament under Chapter 30 was not shown on the record to be a patent or proprietary medicament, so classification under Sub-Heading 3003.20 was not sustained. Recovery of Modvat credit had to proceed under Rule 57-I within limitation, and the extended period required specific material showing fraud, wilful misstatement, suppression, collusion or intent to evade duty. As the notice did not properly establish those grounds and was inconsistent with the applicable Board circular, the denial and reversal of Modvat credit were not upheld. en-us Mon, 28 Oct 2002 00:00:00 +0530 Mon, 27 Sep 2010 16:24:06 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=51685 A bulk drug treated as a medicament under Chapter 30 was not shown on the record to be a patent or proprietary medicament, so classification under Sub-Heading 3003.20 was not sustained. Recovery of Modvat credit had to proceed under Rule 57-I within limitation, and the extended period required specific material showing fraud, wilful misstatement, suppression, collusion or intent to evade duty. As the notice did not properly establish those grounds and was inconsistent with the applicable Board circular, the denial and reversal of Modvat credit were not upheld. Case-Laws Central Excise Mon, 28 Oct 2002 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=51685